Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,090
+1,250 (14.14%)
At close: Aug 28, 2026

KRX:019170 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
48,08947,43341,98643,80041,69127,637
Short-Term Investments
24,22024,07314,47516,24514,22664,599
Trading Asset Securities
---535.69-465.97
Cash & Short-Term Investments
72,30871,50656,46160,58155,91792,702
Cash Growth
30.50%26.65%-6.80%8.34%-39.68%-51.37%
Accounts Receivable
72,78872,53870,16373,66182,28981,865
Other Receivables
903.57784.12,1558,0838,0817,860
Receivables
73,89773,52872,52381,94590,57689,925
Inventory
62,09258,47655,38253,92346,89547,707
Prepaid Expenses
1,1031,2252,757766.581,008900.48
Other Current Assets
2,7322,0012,1991,7192,1471,764
Total Current Assets
212,132206,736189,321198,935196,542232,997
Property, Plant & Equipment
106,163108,728115,398118,638113,760116,884
Long-Term Investments
36,32023,08224,89621,10729,33628,571
Other Intangible Assets
5,2425,0865,0065,7696,9318,971
Long-Term Deferred Tax Assets
1,0721,0872,826475.256,6289,086
Other Long-Term Assets
5,5697,7414,6335,1598,3391,841
Total Assets
366,504352,466342,093350,084361,536398,350

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9,1027,0979,9988,94111,42812,060
Accrued Expenses
16,7606,4079,02113,8567,3007,057
Short-Term Debt
39,19441,19147,30545,000-248.11
Current Portion of Long-Term Debt
2,4002,4001,400---
Current Portion of Leases
526.56764.99951.49932.481,487719.94
Current Income Taxes Payable
22.6300112.5118.11-133.02
Other Current Liabilities
6,2508,7507,0567,5376,9528,332
Total Current Liabilities
74,25566,90975,84476,38527,16728,550
Long-Term Debt
10,80511,3744,600---
Long-Term Leases
356.03126.18340.84218.96441.51212.67
Pension & Post-Retirement Benefits
-----7,065
Other Long-Term Liabilities
3,0523,3293,2182,6983,1692,197
Total Liabilities
88,46881,73984,00379,30130,77838,025

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
27,59227,59227,59227,59227,59227,592
Additional Paid-In Capital
239,763215,780213,592213,592213,592213,592
Retained Earnings
41,58950,77138,94355,331115,830144,925
Treasury Stock
-1,626-8,734-8,734-8,734-8,734-8,734
Comprehensive Income & Other
-30,137-15,434-14,573-18,196-18,673-18,118
Total Common Equity
277,181269,975256,821269,586329,607359,257
Minority Interest
854.45752.641,2691,1961,1511,067
Shareholders' Equity
278,036270,728258,090270,782330,758360,324
Total Liabilities & Equity
366,504352,466342,093350,084361,536398,350

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
53,28155,85654,59746,1511,9281,181
Net Cash (Debt)
19,02715,6501,86414,43053,98891,521
Net Cash Growth
404.17%739.66%-87.08%-73.27%-41.01%-51.54%
Net Cash Per Share
384.05317.6436.46281.491053.181785.35
Filing Date Shares Outstanding
52.7249.2749.2749.2749.2749.27
Total Common Shares Outstanding
52.7249.2751.2651.2651.2651.26
Working Capital
137,877139,826113,477122,550169,375204,447
Book Value Per Share
5257.565479.395009.935258.956429.827008.22
Tangible Book Value
271,940264,889251,814263,817322,676350,286
Tangible Book Value Per Share
5158.145376.174912.275146.416294.626833.22
Land
15,97615,97615,97615,97615,97615,976
Buildings
123,512123,280121,660120,117121,946123,266
Machinery
115,824114,296112,867103,969104,000104,224
Construction In Progress
996.15762.971,1245,4264,231329.3